Sign in

Poul Sørensen

@thepou1.bsky.social
611 followers 2.4K following 28 posts

Danish biotech venture builder living in Paris | Family barista | Kongeblå & Gooner

PostsRepliesMedia
Reposted by Poul Sørensen
Signal Transduction and Targeted Therapy @sigtrans-sttt.bsky.social · 29/09/2026
How can functional RNA molecules move beyond simple protein coding to power next-gen loss- and gain-of-function treatments? This review explores emerging druggable RNAs, optimization, and delivery systems for #clinicaltherapeutics. #STTT #OpenAccess: doi.org/10.1038/s413... #DrugDelivery
RNA therapeutics: current status and future directions
021
Reposted by Poul Sørensen
Nature Reviews Drug Discovery @natrevdrugdiscov.nature.com · 03/09/2026
For readers interested in the opportunities and pitfalls for CAR-T therapies for autoimmune diseases, here's a recent comprehensive Review www.nature.com/articles/s41... rdcu.be/97VgTv2SaRTa
nature.com
Roads and detours for CAR T cell therapy in autoimmune diseases - Nature Reviews Drug Discovery
Following on from its success in eradicating malignant B cells in cancer, chimeric antigen receptor (CAR) T cell therapy has been extended to treat autoimmune diseases. This Review discusses the precl...
063
Reposted by Poul Sørensen
Nature Reviews Drug Discovery @natrevdrugdiscov.nature.com · 17/09/2026
A translational framework for extrahepatic oligonucleotide delivery nature.com/articles/d41... This Comment article outlines an industry-grade quality framework to eliminate methodological artifacts and ensure the translational and commercial viability of novel oligonucleotide platforms
001
Reposted by Poul Sørensen
Nature Reviews Drug Discovery @natrevdrugdiscov.nature.com · 10/07/2026
mRNA technology is one of the platforms being used for n-of-1 therapies. Read about its application in this and a range of other areas such as in vivo CAR-T cell therapies and cancer immunotherapies in this Review www.nature.com/articles/s41... rdcu.be/fteeb
nature.com
Towards mRNA therapeutics 2.0 - Nature Reviews Drug Discovery
mRNA technology is being applied to develop a new generation of therapies for rare and common diseases. This Review discusses insights from clinical studies on mRNA-based therapeutics, including enzym...
041
Reposted by Poul Sørensen
Nature @nature.com · 14/09/2026
An AI system trained on more than 20,000 protein structures from pharmaceutical companies outperforms AlphaFold-like models that use only public data go.nature.com/4AbvcS3
go.nature.com
Drug firms’ secret data supercharge AI protein models
An AI system trained on more than 20,000 protein structures from pharmaceutical companies outperforms AlphaFold-like models that use only public data.
2389
Reposted by Poul Sørensen
Nature Reviews Immunology @natrevimmunol.nature.com · 25/08/2026
Beyond the quick win: rebuilding the foundations of cancer immunotherapy
dlvr.it
Beyond the quick win: rebuilding the foundations of cancer immunotherapy
Nature Reviews Immunology, Published online: 25 August 2026; doi:10.1038/s41577-026-01352-9Checkpoint inhibitors, CAR T cells and bispecific T cell engagers have demonstrated the transformative potential of cancer immunotherapy. However, progress has slowed as efforts have focused on replicating PD-(L)1 blockade successes, highlighting the need for deeper understanding of human cancer immunity.
031
Reposted by Poul Sørensen
Nature @nature.com · 19/08/2026
Supercentenarians — people aged 110 and older — not only enjoy unusually long lives but they also seem to fend off diseases of old age including heart disease, dementia and cancer go.nature.com/4g4OLnk
go.nature.com
How do people live beyond 110? Abundance of cancer-killing cells might be key
Research on people 110 years and older reveals an immune system that continues to adapt.
1366
Reposted by Poul Sørensen
Ruth Montgomery @rrmsky.bsky.social · 18/08/2026
The most pressing questions in immunology — why do people respond differently to infection, vaccination or therapy? Why do some develop chronic inflammatory disease while others remain resilient? See high-dimensional public data resources. @hipcproject.bsky.social @yalemed.bsky.social rdcu.be/fAwms
nature.com
From data to discovery: a unified framework for human immunology
Nature Immunology - High-throughput, high-dimensional profiling technologies have transformed the ability to generate and test hypotheses of human immunology. Investment in infrastructure has...
073
Poul Sørensen @thepou1.bsky.social · 03/08/2026
The dark horse of biology: how RNA is becoming a nanotool maker’s dream www.nature.com/articles/d41...
nature.com
The dark horse of biology: how RNA is becoming a nanotool maker’s dream
Scientists are harnessing its ability to fold, switch and reorganize itself to create a new generation of cellular technologies.
021
Reposted by Poul Sørensen
Andrii Bugai @abugai.bsky.social · 17/06/2026
Check out our latest research, just published in Nature @nature.com @molbiolau.bsky.social @au.dk Molecular basis of polyadenylated RNA fate determination in the nucleus www.nature.com/articles/s41...
nature.com
Molecular basis of polyadenylated RNA fate determination in the nucleus - Nature
Biochemical, structural and cell biological analyses reveal that UAP56 (DDX39B) assembles with a TREX-2–like module that redirects non-functional polyadenylated RNAs from export to degradati...
16027
Reposted by Poul Sørensen
Nature Biotechnology @natbiotech.nature.com · 11/06/2026
Biotech’s coming of age Biotech is back. But continued investor caution, the rise of China and fast-moving AI are changing the sector’s contours www.nature.com/articles/s41...
nature.com
Biotech’s coming of age - Nature Biotechnology
Biotech is back. But continued investor caution, the rise of China and fast-moving AI are changing the sector’s contours.
042
Reposted by Poul Sørensen
Sholto David @sholtodavid.bsky.social · 02/06/2026
Today I'm posting a new blog about an astonishing scientific own goal. Hundreds of papers have reported using a totally wrong antibody to investigate the tumor suppressor p16. This mistake has happened because scientists have muddled the names of two proteins. forbetterscience.com/2026/06/02/m...
1617078
Reposted by Poul Sørensen
Eric Topol @erictopol.bsky.social · 02/06/2026
Big progress vs cancer, folks. The kind of event curves from randomized trials that we've not seen before for a couple of the most deadly cancers. Congrats to the oncology research community for getting these trial done.
291299292
Reposted by Poul Sørensen
The Lancet @thelancet.com · 29/05/2026
Neurological disorders are the leading cause of disability. But neurology is transforming. “Neurology is entering a biologically informed era with unprecedented potential to prevent or delay disease onset and reduce disability”, states our latest Editorial. Read: spkl.io/6332776UIP
Blue Editorial quote card on a new era in neurology: “Neurology is entering a biologically informed era with unprecedented potential to prevent or delay disease onset and reduce disability.”
0165
Reposted by Poul Sørensen
Eric Topol @erictopol.bsky.social · 24/05/2026
If you're interested in the hot (yet complex) field of cancer immunotherapies with >2,000 approved or in the works, I've done a rundown and future outlook erictopol.substack.com/p/the-remark...
9425114
Reposted by Poul Sørensen
Arsenal FC @arsenalfc.bsky.social · 19/05/2026
The Arsenal. Your Premier League champions.
10237921164
Poul Sørensen @thepou1.bsky.social · 09/05/2026
The broader sense of nonsense www.cell.com/trends/bioch...
cell.com
The broader sense of nonsense
The term ‘nonsense-mediated mRNA decay’ (NMD) was initially coined to describe the translation-dependent degradation of mRNAs harboring premature termination codons (PTCs), but it is meanwhile known t...
031
Reposted by Poul Sørensen
Nature Reviews Immunology @natrevimmunol.nature.com · 24/04/2026
ICYMI: The long-lived immune system of centenarians
dlvr.it
The long-lived immune system of centenarians
Nature Reviews Immunology, Published online: 23 April 2026; doi:10.1038/s41577-026-01291-5What is unique about the immune system of people who live to extreme old age? Here the authors describe that centenarians may achieve such longevity through several mechanisms, including limiting the pathological effects of inflammageing and immunosenescence, preservation of immune surveillance, sustained gut microbial diversity and maintenance of intestinal barrier integrity.
0151
Poul Sørensen @thepou1.bsky.social · 23/03/2026
www.linkedin.com/posts/hdgrat...
linkedin.com
#hdgratitudeday #huntingtonsdisease #raredisease | Inverna Therapeutics
Today, on Huntington’s Disease Gratitude Day, we honor the strength and commitment of the HD community. We recognize the collective progress made through collaboration and the shared foundation it cr...
010
Poul Sørensen @thepou1.bsky.social · 19/03/2026
Thymus health is a predictor of lifelong well-being and immunotherapy effectiveness www.nature.com/articles/d41...
nature.com
Thymus health is a predictor of lifelong well-being and immunotherapy effectiveness
It was thought that the thymus serves its purpose for the immune system early in life. Insights about the organ in adults reveal its importance for later well-being.
010
Reposted by Poul Sørensen
Inverna Therapeutics @invernatx.com · 18/03/2026
Our CEO Poul Sørensen shared our latest progress this morning at RNA Leaders in Vienna #RNATherapeutics #Pseudoexon #Parkinsons #Huntingtons #RNAleaders
041
Poul Sørensen @thepou1.bsky.social · 15/03/2026
Very much looking forward to this www.linkedin.com/posts/poulso...
linkedin.com
#rnatherapeutics #pseudoexons #rnaleaders #precisionmedicine | Poul Sørensen
I’m looking forward to speaking at RNA Leaders Europe 2026 in Vienna March 17-19 🧬 At Inverna Therapeutics we are developing precision RNA therapeutics that activate disease-relevant pseudo-exons wi...
010
Poul Sørensen @thepou1.bsky.social · 04/03/2026
Immune reset and immune retune: approaching cure? www.nature.com/articles/s41... #immunetolerance #cure
nature.com
Immune reset and immune retune: approaching cure? - Nature Reviews Rheumatology
The emergence of potent depletion therapies for the treatment of refractory autoimmunity has led to the concept of immune reset. Understanding whether immune reset equates to cure, and whether cure is...
010
Poul Sørensen @thepou1.bsky.social · 04/03/2026
All set for an exciting day at Biocapital Europe in Amsterdam #Inverna #BioCapital2026 #Biotech #RNA #SpliceModulation #Neurodegeneration #ParkinsonsDisease #HuntingtonsDisease #PrecisionMedicine #BiotechInvesting #Partnering
030
Poul Sørensen @thepou1.bsky.social · 16/02/2026
Huntington’s disease is the best investment in neuroscience today www.sciencedirect.com/science/arti... #Huntingtons #Neuroscience #Investment
sciencedirect.com
Huntington’s disease is the best investment in neuroscience today
Huntington’s disease (HD) is usually described as rare, tragic, and intractable. Yet, HD offers a strategically unique entry point for neuroscience. W…
195
Poul Sørensen @thepou1.bsky.social · 14/02/2026
A small polymerase ribozyme that can synthesize itself and its complementary strand | Science www.science.org/doi/10.1126/...
science.org
A small polymerase ribozyme that can synthesize itself and its complementary strand
The emergence of a chemical system capable of self-replication and evolution is a critical event in the origin of life. RNA polymerase ribozymes can replicate RNA, but their large size and structural ...
020
Reposted by Poul Sørensen
FAACT | Food Allergy @faactnews.bsky.social · 17/12/2025
#BreakingNews DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN® #PeanutPatch in Peanut Allergic Children Aged 4-7 Years Read the full press release here: dbv-technologies.com/press_releas... #FoodAllergy #FoodAllergies #FoodAllergyResearch #PeanutAllergy
031
Reposted by Poul Sørensen
Javi Ibarrondo @jibarrondo.bsky.social · 03/12/2025
A vaccine targeting human IgE induces long-term protection against anaphylaxis in humanized mice | Science Translational Medicine www.science.org/doi/10.1126/... 🧪
science.org
A vaccine targeting human IgE induces long-term protection against anaphylaxis in humanized mice
A conjugate vaccine targeting human IgE induces long-term production of neutralizing antibodies and protects against anaphylaxis in humanized mice.
0207
Reposted by Poul Sørensen
Shicheng Guo @shihcheng.bsky.social · 15/10/2025
Neuronal aging leads to mislocated splicing proteins and unchecked stress. Aged neurons lose RNA-binding proteins. PMID:40456907, Nat Neurosci 2025, @NatureNeuro doi.org/10.1038/s41593-025-01952-z #Medsky #Pharmsky #RNA #ASHG #ESHG 🧪
doi.org
Neuronal aging causes mislocalization of splicing proteins and unchecked cellular stress | Nature Neuroscience
Aging is one of the most prominent risk factors for neurodegeneration, yet the molecular mechanisms underlying the deterioration of old neurons are mostly unknown. To efficiently study neurodegeneration in the context of aging, we transdifferentiated primary human fibroblasts from aged healthy donors directly into neurons, which retained their aging hallmarks, and we verified key findings in aged human and mouse brain tissue. Here we show that aged neurons are broadly depleted of RNA-binding proteins, especially spliceosome components. Intriguingly, splicing proteins—like the dementia- and ALS-associated protein TDP-43—mislocalize to the cytoplasm in aged neurons, which leads to widespread alternative splicing. Cytoplasmic spliceosome components are typically recruited to stress granules, but aged neurons suffer from chronic cellular stress that prevents this sequestration. We link chronic stress to the malfunctioning ubiquitylation machinery, poor HSP90α chaperone activity and the fai
0153
Reposted by Poul Sørensen
Petter Brodin @petterbrodin.bsky.social · 04/12/2025
Me and a few leading colleagues discuss female-specific immune systems in health and disease. By @starrevartan.bsky.social in @newscientist.com www.newscientist.com/article/2501...
newscientist.com
Women have supercharged immune systems and we now know why
Being born with two X chromosomes brings a host of health benefits, and recognising this could lead to personalised medical treatments for men and women
2236
Poul Sørensen @thepou1.bsky.social · 02/12/2025
Nice review on "Tolerance-inducing therapies in coeliac disease — mechanisms, progress and future directions" and happy to see one of my companies Allero Therapeutics highlighted #autoimmune #antigenspecific #immunetolerance #celiacdisease www.linkedin.com/posts/elenak...
linkedin.com
Tolerance-inducing therapies in coeliac disease — mechanisms, progress and future directions - Nature Reviews Gastroenterology & Hepatology | Elena Kotsiliti
As immune tolerance is trending now, have a look at this Review on 'Tolerance-inducing therapies in coeliac disease — mechanisms, progress and future directions' by Ludvig M. Sollid that was published...
010
Reposted by Poul Sørensen
now.arsenal @nowarsenal.bsky.social · 23/11/2025
FT: Arsenal 4-1 Tottenham What colour is North London? And who is Eberechi Eze? Six points clear at the top and seven points clear of Manchester City. And we’re just getting started… Thoughts on the win?
1441
Reposted by Poul Sørensen
MedCity News @medcitynews.com · 13/11/2025
Novel Novartis Malaria Drug Shows Promise to Become New Asset Against Resistant Strains medcitynews.com/2025/11/novartis-ma…
medcitynews.com
Novel Novartis Malaria Drug Shows Promise to Become New Asset Against Resistant Strains
Phase 3 results for the Novartis malaria drug “GanLum” show it was comparable to the standard of care and led to cure rates that top the threshold recommended by the World Health Organization. If approved, this new combination drug would become the first novel malaria therapy in more than 25 years.
021
Poul Sørensen @thepou1.bsky.social · 08/11/2025
This year’s #NobelPrize celebrates breakthroughs in immune tolerance. Curious how it shapes #immunotherapy? Join us in Aarhus on Nov 27 for the annual Aarhus Immunotherapy Symposium with a stellar lineup of speakers ! conferences.au.dk/ais
conferences.au.dk
Aarhus Immunotherapy Symposia
020
Reposted by Poul Sørensen
Nature Portfolio @natureportfolio.nature.com · 29/10/2025
A paper in Nature reports that mRNA vaccines targeting SARS-CoV-2, COVID-19, also sensitize tumours to immune checkpoint inhibitors. #medsky 🧪
go.nature.com
SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade - Nature
mRNA vaccines targeting SARS-CoV-2 also sensitize tumours to immune checkpoint inhibitors.
05423
Poul Sørensen @thepou1.bsky.social · 03/11/2025
Conversion of pathogenic T cells into functionally stabilized Treg cells for antigen-specific immunosuppression in pemphigus vulgaris www.science.org/doi/10.1126/...
science.org
Conversion of pathogenic T cells into functionally stabilized Treg cells for antigen-specific immunosuppression in pemphigus vulgaris
Functionally stable regulatory T cells converted in vitro from pathogenic T cells can confer antigen-specific immunosuppression in pemphigus vulgaris.
010
Poul Sørensen @thepou1.bsky.social · 29/10/2025
Exciting news from Inverna ! 🎉 www.linkedin.com/posts/invern...
linkedin.com
Inverna Therapeutics announces the formation of its Scientific Advisory Board consisting of world-renowned leaders in RNA therapeutics and neurodegenerative research | Inverna Therapeutics
Inverna Therapeutics is delighted to announce the formation of our new Scientific Advisory Board (SAB)🚀 We welcome world-renowned leaders in RNA therapeutics and neurodegenerative research to advance...
010
Reposted by Poul Sørensen
Inverna Therapeutics @invernatx.com · 09/10/2025
Big news today! 🎉 #MJFF #RNAtherapeutics #Parkinsondisease #RNAsplicingmodulation #Pseudoexon #Innovation
linkedin.com
#invernatherapeutics #mjff #grant #parkinsonsdisease #lrrk2 #biotech #startup #neuroscience #innovation | Inverna Therapeutics
🎉 Exciting news from Inverna Therapeutics! 🚀 We’re honored to announce that Inverna has been awarded a grant from the Michael J. Fox Foundation for Parkinson’s Research (MJFF) as part of the LRRK2 Inv...
061
Poul Sørensen @thepou1.bsky.social · 06/10/2025
Extremely well deserved ! #immunetolerance
020
Reposted by Poul Sørensen
Pure Science @purescience.news · 30/09/2025
Huntington's Breakthrough May Not Be The Success It Seems, Expert Cautions #Science #HealthandMedicine #Neurology #HuntingtonsDisease #MedicalResearch
purescience.news
Huntington's Breakthrough May Not Be The Success It Seems, Expert Cautions
Time will tell.
011
Poul Sørensen @thepou1.bsky.social · 19/08/2025
Nice to see the RNA splicing modulation area developing - keep an eye on @invernatx.com and their more precise and rationally designed oligonucleotide based approach
040
Reposted by Poul Sørensen
Greg Folkers @gregfolkers.bsky.social · 15/08/2025
Nature: Cancelling mRNA studies is the highest irresponsibility go.nature.com/3HDx4wD cc Jay Bhattacharya
10634247
Reposted by Poul Sørensen
Arsenal FC @arsenalfc.bsky.social · 10/07/2025
NORGAARD SIGNS! www.arsenal.com/news/christi...
arsenal.com
Christian Norgaard signs for Arsenal
We’re delighted to announce that the Denmark international midfielder has joined us from Brentford
42039
Poul Sørensen @thepou1.bsky.social · 17/05/2025
Changes in the gut that lead to an immune “scar” could be the cause of ongoing celiac disease symptoms www.nature.com/articles/s41...
nature.com
040
Reposted by Poul Sørensen
arseblog @arseblog.com · 08/04/2025
What a night, what a performance from this far from 100% team, one of the great European nights at the Emirates. Declan Rice has produced two of the greatest free kicks you'll ever see at this level, and we 100% deserved that third goal too. Incredible. This team deserves so much love. #arsenal
1573453393
Reposted by Poul Sørensen
Rufus Gifford @rufusgifford.bsky.social · 29/03/2025
So grateful to share a bit of my experience with @maddow.msnbc.com last night. Thanks so much for having me. www.msnbc.com/rachel-maddo...
msnbc.com
'This is shameful': Trump sows animosity and mistrust abroad, degrading Americans in the process
Rufus Gifford, former U.S. ambassador to Denmark, talks with Rachel Maddow about the animosity and mistrust Donald Trump is sowing among even allied nations, and the shock of betrayal people around th...
3131683
Reposted by Poul Sørensen
bioRxiv Immunology @biorxiv-immuno.bsky.social · 29/03/2025
Myelin antigen-specific effector CD8+ T cells induce chronic CNS autoimmunity in a CD4+ T cell-dependent manner. www.biorxiv.org/content/10.1101/202…
031
Reposted by Poul Sørensen
The Guardian @theguardian.com · 29/03/2025
Denmark hits back at ‘tone’ of US vice-president’s criticism over Greenland
theguardian.com
Denmark hits back at ‘tone’ of US vice-president’s criticism over Greenland
‘This is not how you talk to your close allies,’ says Danish foreign minister Lars Løkke Rasmussen Denmark has hit back against JD Vance’s comments that Copenhagen has not done enough for Greenland. The US vice-president made his remark on Friday during a trip to the Pituffik space base in north-western Greenland, viewed by both Copenhagen and Nuuk as a provocation. Continue reading...
5242484
Poul Sørensen @thepou1.bsky.social · 29/03/2025
Indeed bad news for we beer and cheese lovers - better for wine aficionados...
020